drugset / Trial / NCT01382602

Autologous Muscle Derived Cells Female Stress Urinary Incontinence Clinical Study

NCT01382602 ↗

Phase 3 Completed 150 enrolled Cook MyoSite
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a clinical trial to study the safety and effectiveness of Autologous Muscle Derived Cells for Urinary Sphincter Repair (AMDC-USR) for the treatment of female stress urinary incontinence (SUI).

Timeline

Start
2011-11-04
Primary completion
2016-02-03
Completion
2017-01-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Iltamiocel Cell therapy 1.5e+08 cells Other